Aqr Capital Management LLC Alkermes Plc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 831,250 shares of ALKS stock, worth $23.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

831,250

Previous 803,504 3.45%

Holding current value

$23.9 Million

Previous $19.4 Million 20.15%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $638,435 - $792,148	27,746 Added 3.45%	831,250 $23.3 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $8.8 Million - $10.3 Million	379,240 Added 89.39%	803,504 $19.4 Million
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $1.04 Million - $1.28 Million	39,403 Added 10.24%	424,264 $11.5 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $413,111 - $506,976	17,677 Added 4.81%	384,861 $10.7 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $7.41 Million - $8.72 Million	272,723 Added 288.71%	367,184 $10.3 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $1.14 Million - $1.36 Million	-40,318 Reduced 29.91%	94,461 $2.96 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $1.52 Million - $1.75 Million	-60,160 Reduced 30.86%	134,779 $3.8 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $289,410 - $346,131	13,191 Added 7.26%	194,939 $5.09 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1.74 Million - $2.52 Million	79,170 Added 77.18%	181,748 $4.06 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $49,473 - $57,231	1,874 Added 1.86%	102,578 $3.06 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $929,859 - $1.13 Million	-40,306 Reduced 28.58%	100,704 $2.65 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $657,819 - $982,899	30,639 Added 27.76%	141,010 $3.28 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $683,619 - $939,866	-29,252 Reduced 20.95%	110,371 $3.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $1.06 Million - $1.42 Million	56,282 Added 67.53%	139,623 $3.42 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $4,916 - $6,264	-270 Reduced 0.32%	83,341 $1.56 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $7.23 Million - $10.4 Million	-469,853 Reduced 84.89%	83,611 $1.66 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $15.7 Million - $20.1 Million	-973,259 Reduced 63.75%	553,464 $9.03 Million
Q2 2020 Aug 17, 2020	SELL	$13.31 - $19.41 $7.26 Million - $10.6 Million	-545,227 Reduced 26.31%	1,526,723 $29.5 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $1.99 Million - $3.24 Million	152,571 Added 7.95%	2,071,950 $29.9 Million
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $3.31 Million - $4.16 Million	-191,571 Reduced 9.08%	1,919,379 $39 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $5.17 Million - $6.44 Million	-265,048 Reduced 11.16%	2,110,950 $40 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $21.1 Million - $36.6 Million	981,355 Added 70.37%	2,375,998 $53.1 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $39 Million - $50 Million	1,371,560 Added 5941.86%	1,394,643 $49.9 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $369,813 - $590,457	13,236 Added 134.42%	23,083 $681,000
Q3 2018 Nov 15, 2018	SELL	$38.6 - $46.12 $327,791 - $391,651	-8,492 Reduced 46.31%	9,847 $418,000
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $219,226 - $277,600	-5,405 Reduced 22.76%	18,339 $755,000
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $360,044 - $451,718	-6,716 Reduced 22.05%	23,744 $1.38 Million
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $516,101 - $599,430	-10,822 Reduced 26.21%	30,460 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $2.03 Million - $2.25 Million	41,282	41,282 $2.1 Million

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Alkermes Plc. Transaction History